ArticlePLoS medicine2025

Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study.

Rylee McGonigle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.